BlackRock, Inc. (BLK) 13D/13G Filings for Adamas Pharmaceuticals, Inc. (ADMS)

BlackRock, Inc. 13D and 13G filings for Adamas Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-07-10
10:39 am
Sale
2020-06-30 13G Adamas Pharmaceuticals, Inc.
ADMS
BLACKROCK INC
BLK
598,070
2.100%
-1,137,239decrease
(-65.54%)
Filing